NHS England has formed a Cross-system Sepsis Programme Board – a group of experts from across the health and care system, to take action to improve the identification, diagnosis and management of sepsis in children, young people and adults across the NHS.
What is sepsis?
Sepsis is a common and potentially life-threatening condition where the body’s immune system goes into overdrive in response to an infection, setting off a series of reactions that can lead to widespread inflammation, swelling and blood clotting. This can lead to a significant decrease in blood pressure, which can mean the blood supply to vital organs such as the brain, heart and kidneys is reduced and there is a significant risk of long-term disability or death. Sepsis is almost unique among acute conditions in that it affects all age groups.
Why must we take action?
In the UK, it is estimated that 102,000 people develop sepsis each year, and around 36,800 people die as a result. In comparison, cardiovascular disease (including heart attacks) claims approximately 160,000 lives per year, stroke more than 40,000 and lung cancer more than 35,000. If we can achieve more consistent early identification and treatment of sepsis there is considerable scope to improve survival and reduce long-term disability for patients as well as an opportunity to reduce health care costs. NHS England has brought together partners from across the health system to agree a range of actions to improve the recognition and management of patients with sepsis.
Who are the members of the Cross-system Sepsis Programme Board?
The following individuals and organisations are represented on the Programme Board, with additional expert input into detailed work streams:
|Organisation||Member and role|
|Celia Ingham Clark, Director, Reducing Premature Mortality (CHAIR)||NHS England|
|Mike Durkin, Joint Chair, Director, Patient Safety(Co- CHAIR)||NHS England|
|Alastair Henderson, Chief Executive||Academy of Medical Royal Colleges|
|Andrew Frankel, Postgraduate Dean||Health Education South London|
|Damian Riley, Regional Medical Director, North||NHS England|
|Derek Bell, Acute Physician, Chelsea & Westminster Hospital NHS Foundation||Expert clinician|
|Edward Baker, Deputy Chief Inspector of Hospitals||Care Quality Commission (CQC)|
|Gerrard Phillips, Senior Censor, Vice President for Education & Training, RCP London||Royal College of Physicians|
|Graham Prestwich, Lay Member, Patient and Public Involvement, Leeds North Clinical Commissioning Group||Representative of patients, carers and the public|
|Hugo Mascie-Taylor, Medical Director||Monitor|
|Ian Gould, Consultant Microbiologist||Royal College of Pathologists|
|Ian Maconochie, Consultant in Paediatric Accident & Emergency Medicine||Royal College of Paediatrics and Child Health|
|Isabel Oliver, Director of the Field Epidemiology Service||Public Health England (PHE)|
|Jacqueline Barnes, Chief Nurse, Coventry and Rugby CCG & Warwickshire North CCG||CCG representative|
|Jacqueline Cornish, National Clinical Director, Children, Young People & Transition to Adulthood||NHS England|
|Jason Yiannikkou, Deputy Director, Quality Improvement Team||Department of Health|
|Jeff Keep, Consultant and Honorary Senior Lecturer in Emergency Medicine & Major Trauma, King’s College Hospital, London||Royal College of Emergency Medicine|
|Jeremy Tong, Consultant Paediatric Intensivist, University Hospitals of Leicester NHS Trust||Expert clinician|
|Jonathan Benger, National Clinical Director||NHS England|
|Jonathan Hope, Statistical Section Head, Statistical Response Unit||HSCIC|
|Karen Warner, Associate Director of Quality & Nursing, Yorkshire Ambulance Service||Ambulance services representative|
|Kathy McLean, Medical Director||NHS Trust Development Authority (NHS TDA)|
|Mark Baker, Director of the Centre of Clinical Practice||National Institute for Health and Care Excellence (NICE)|
|Martin Severs, Chief Executive||Health and Social Care Information Centre (HSCIC)|
|Martyn Diaper, Head of Patient Safety (Primary Care)||NHS England|
|Mike Surkitt-Parr, Head of Patient Safety||NHS England|
|Paul Mackenzie, Patient safety Collaborative Sepsis Cluster Lead||North West Coast Academic Health Science Network|
|Paul Stonebrook, Health Improvement Directorate, National Programme Delivery||Department of Health|
|Philip Howard, Consultant Pharmacist in Antimicrobials at the Leeds Teaching Hospitals NHS Trust||Royal Pharmaceutical Society|
|Prof Gordon Carlson. Consultant Colorectal and General Surgeon||Royal College of Surgeons of England|
|Richard Healicon, Programme Delivery Lead, Domain 1 – Living Longer Lives||NHS Improving Quality (NHSIQ)|
|Richard Jennings, Infectious Diseases Specialist, Whittington Hospital||Expert clinician|
|Ron Daniels, Chief Executive||UK Sepsis Trust|
|Simon Stockley, General Practitioner||Royal College of General Practitioners|
|Suman Shrestha, Advanced Critical Care Practitioner||Royal College of Nursing|
|Tracy Nicholls, Head of Clinical Quality, East of England Ambulance Service NHS Trust||Ambulance services representative|
What is the Cross-system Sepsis Programme Board doing?
The Programme Board was established to:
- Provide clinical expertise and advice on the current barriers and issues to driving quality improvement, and how these can be overcome;
- Advise on the overall strategy required to drive improvement in the identification and treatment of sepsis; and
- Identify those areas in which efforts need to be targeted in the short, medium and long-term, making decisions and/or recommendations about those tools and levers needed to drive improvement in 2015/16, 2016/17, and beyond.
NHS England, in partnership with the Programme Board member organisations, has published a cross-system action plan ‘Improving outcomes for patients with sepsis’ outlining a number of actions that will be taken across the health and care landscape.
This report sets out some of the key challenges within these themes, and the actions that organisations across the health and care system plan to take. This document is designed to give the public an overview of what actions are being taken to address sepsis. It should also be of use to health and care professionals, those working in national organisations, and commissioners, in highlighting some of the key issues identified and outlining the steps that will be taken.
The focus will now be on putting this plan into action. We expect actions to be taken forward by the relevant organisations represented on the Board and will review the need to reconvene in the spring of 2016.